Skip to main content
Menu
MX

Virtually any target can be quickly and easily measured using Alpha technology, an improved alternative to ELISAs.

Such targets include biomarkers, cytokines, phospho-proteins, receptor-ligand interactions, biochemical enzymes, second messenger levels, DNA, RNA, proteins, protein-protein interactions, peptides, sugars, and small molecules.

Choose the homogeneous Alpha assay right for you:

AlphaLISA™ – AlphaLISA products are designed for the detection of molecules of interest in serum, plasma, cell culture supernatants, or cell lysates in a sensitive, quantitative, reproducible, and user-friendly assay. Choose from a large portfolio of ready-to-use kits, or utilize the Alpha toolbox portfolio to create your own assay.

AlphaLISA™ SureFire® Ultra – Protein phosphorylation is a dynamic process, meticulously regulated by kinase and phosphatase cascades. This regulation is crucial for many cellular processes and has been identified as a key mechanism underlying various diseases. AlphaLISA SureFire Ultra assays provide a robust and reliable method for quantifying a targeted phosphorylation event in cell-based experiments and are less time consuming than Western Blotting.
 


The benefits of Alpha technology

  • Ease-of-use: homogeneous assay with no wash requirement and no separation steps
  • Fast: results in 3 hours for most applications
  • High sensitivity: detect down to femtogram levels of target
  • Large dynamic range: 4-5 logs
  • Compatible with many sample types: serum, plasma, cerebrospinal fluid (CSF), tissue extracts, cell culture supernatants, cell lysates, and more
16054_alpha_valueprops-800px.jpg


For research use only. Not for use in diagnostic procedures.

Alpha Assays

Explore our solutions

Target Area

Target area

Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.

  • Biologics screening and characterization: Explore assays for biologics screening, mechanism-of-action studies, and biomanufacturing.
  • Biomarker detection: Accurate detection and quantitation of molecular targets across serum, plasma, culture supernatants, cellular lysates, and other sample types.
  • Cell and gene therapy: Discover and advance cell and gene therapy research with bioanalytical immunoassays for CGT development.
  • Cytokines: Access a comprehensive range of cytokine assay kits, including interleukins, interferons, chemokines, tumor necrosis factors, and lymphokines.
  • Epigenetics: Leverage our epigenetics toolbox, designed to detect specific methylation and acetylation marks on histone peptide substrates.
  • GPCRs: Measure cAMP levels and track downstream protein phosphorylation with functional GPCR assays.
  • Protein kinases: Explore an extensive portfolio of protein phosphorylation assays, available in cell-based or biochemical no-wash formats.
  • Protein-protein interactions: Utilize highly sensitive assays to study protein interactions involved in a range of biological processes.
  • Targeted protein degradation: Monitor protein expression levels and characterize the mechanism of action using our total and phospho kits.

Explore cell-based and biochemical assays by target area of interest, including cell and gene therapy, GPCRs, targeted protein degradation, and more.

  • Biologics screening and characterization: Explore assays for biologics screening, mechanism-of-action studies, and biomanufacturing.
  • Biomarker detection: Accurate detection and quantitation of molecular targets across serum, plasma, culture supernatants, cellular lysates, and other sample types.
  • Cell and gene therapy: Discover and advance cell and gene therapy research with bioanalytical immunoassays for CGT development.
  • Cytokines: Access a comprehensive range of cytokine assay kits, including interleukins, interferons, chemokines, tumor necrosis factors, and lymphokines.
  • Epigenetics: Leverage our epigenetics toolbox, designed to detect specific methylation and acetylation marks on histone peptide substrates.
  • GPCRs: Measure cAMP levels and track downstream protein phosphorylation with functional GPCR assays.
  • Protein kinases: Explore an extensive portfolio of protein phosphorylation assays, available in cell-based or biochemical no-wash formats.
  • Protein-protein interactions: Utilize highly sensitive assays to study protein interactions involved in a range of biological processes.
  • Targeted protein degradation: Monitor protein expression levels and characterize the mechanism of action using our total and phospho kits.
Therapeutic Area

Therapeutic area

Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.

  • Autoimmune diseases: Comprehensive reagents for autoimmune disease research, including rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, and more.
  • Obesity, diabetes, and metabolic diseases: Solutions for drug discovery in obesity, diabetes, and metabolic diseases, featuring assays for biomarker detection, protein analysis, and GPCR research.
  • Fibrosis: Ready-to-use assays for monitoring biomarkers, phosphoproteins, and transcription factors relevant to fibrotic disease research.
  • Immuno-oncology: Assays for studying immunity and immune cells, covering protein, biomarker, and cytokine detection, as well as cell toxicity and proliferation.
  • Oncology: A comprehensive oncology portfolio, including assays for cytokines, biomarkers, phospho-proteins, cell proliferation, cytotoxicity, and more.
  • Neuroscience: A wide range of neuroscience assays to support research in neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington's disease.
  • Virology: Assay technologies for viral studies, enabling assessment of viral life cycles and antiviral immune responses with streamlined workflows.

Explore cell-based and biochemical assays by your therapeutic area of research, including oncology, neuroscience, metabolic diseases, and more.

  • Autoimmune diseases: Comprehensive reagents for autoimmune disease research, including rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, and more.
  • Obesity, diabetes, and metabolic diseases: Solutions for drug discovery in obesity, diabetes, and metabolic diseases, featuring assays for biomarker detection, protein analysis, and GPCR research.
  • Fibrosis: Ready-to-use assays for monitoring biomarkers, phosphoproteins, and transcription factors relevant to fibrotic disease research.
  • Immuno-oncology: Assays for studying immunity and immune cells, covering protein, biomarker, and cytokine detection, as well as cell toxicity and proliferation.
  • Oncology: A comprehensive oncology portfolio, including assays for cytokines, biomarkers, phospho-proteins, cell proliferation, cytotoxicity, and more.
  • Neuroscience: A wide range of neuroscience assays to support research in neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington's disease.
  • Virology: Assay technologies for viral studies, enabling assessment of viral life cycles and antiviral immune responses with streamlined workflows.
bg-element-listing-page bg-element-listing-page-mobile
Products & Services
Resource Library
Filters
Expand All|Collapse All
Product Type
Application
Bead Type or Material
Brand
Cellular or Signaling Pathway
Detection Modality
Host Species
Predicted Species Reactivity
Product Group
Target
Target Class
Target Species
Therapeutic Area
Sort by: Recommended
Recommended
Product Name A-Z
Product Name Z-A
1 - 25 of 1697 Products and Services
New
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image

The AlphaLISA™ Human Neurofilament Light (NF-L) Kit is designed for the simple and rapid quantification of human NF-L in cell supernatants.

Part Number: AL3199HV, AL3199C, AL3199F
New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-Rb (Thr821) assay is a sandwich immunoassay for quantitative detection of phospho-Rb in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Mouse Total RIPK1 assay is a sandwich immunoassay for quantitative detection of total RIPK1 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human Phospho-PERK (Thr982) assay is a sandwich immunoassay for quantitative detection of phospho-PERK in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human Total Progesterone Receptor assay is a sandwich immunoassay for quantitative detection of total Progesterone Receptor in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-PRAS40 (Thr246) assay is a sandwich immunoassay for quantitative detection of phospho-PRAS40 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human Phospho-eNOS (Ser1177) assay is a sandwich immunoassay for quantitative detection of phospho-eNOS in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human Total p16 INK4A assay is a sandwich immunoassay for quantitative detection of total p16 INK4A in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human Total PI3K p85 assay is a sandwich immunoassay for quantitative detection of total PI3K p85 in cellular lysates using Alpha Technology.

New
AlphaLISA Sandwich Anti-analyte Conjugated Acceptor Bead image

The AlphaLISA™ Detection Kit for Hepatitis B Virus Surface antigen (HBeAg) enables the quantitative determination of HBeAg in cell culture media and buffer using a homogeneous AlphaLISA assay (no wash steps).

Part Number: AL3201HV, AL3201C, AL3201F
New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Mouse Phospho-RIPK1 (Ser321) assay is a sandwich immunoassay for quantitative detection of phospho-RIPK1 in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total MEK2 assay is a sandwich immunoassay for quantitative detection of total MEK2 in cellular lysates using Alpha Technology.

New
FCGR2B/CD32b AlphaLISA Binding Kit, 500 Assay Points

This kit is designed for the detection of binding between FCGR1 (CD64) and human IgG Fc fragment using a homogeneous AlphaLISA™ assay (no wash steps). This assay can facilitate the design and development of antibody therapetics by using competitive binding.

Part Number: AL3200C, AL3200F
New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human Phospho-PI3K p85 (Tyr467) assay is a sandwich immunoassay for quantitative detection of phospho-PI3K p85 in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total NFκB2 p100 assay is a sandwich immunoassay for quantitative detection of total NFκB2 p100 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-MEK2 (Ser217/221) assay is a sandwich immunoassay for quantitative detection of phospho-MEK2 in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human Total p21 CiP1 assay is a sandwich immunoassay for quantitative detection of total p21 CiP1 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human Phospho-RIPK1 (Ser320) assay is a sandwich immunoassay for quantitative detection of phospho-RIPK1 in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total NFκB2 p100/p52 assay is a sandwich immunoassay for quantitative detection of total NFκB2 p100/p52 in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total PRAS40 assay is a sandwich immunoassay for quantitative detection of total PRAS40 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human Phospho-eNOS (Thr495) assay is a sandwich immunoassay for quantitative detection of phospho-eNOS in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total TRAF3 assay is a sandwich immunoassay for quantitative detection of total TRAF3 in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-Rb (Thr826) assay is a sandwich immunoassay for quantitative detection of phospho-Rb in cellular lysates using Alpha Technology.

New
AlphaLISA Surefire Ultra Total Protein

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Total BAD assay is a sandwich immunoassay for quantitative detection of total BAD in cellular lysates using Alpha Technology.

New
AlphaLISA SureFire Ultra Phospho-Protein image

The AlphaLISA™ SureFire® Ultra™ Human and Mouse Phospho-BAD (Ser136) assay is a sandwich immunoassay for quantitative detection of phospho-BAD in cellular lysates using Alpha Technology.

Filters
Expand All|Collapse All
Resource Type
Sort by: Resource Name A-Z
Resource Name A-Z
Resource Name Z-A
1 - 25 of 149 Resources
Application Note
Application Note
A comparative study of two immunoassay platforms to determine lentivirus titer for CAR-T development

The main vectors of gene therapy in research are viruses. The most popular tool for gene delivery is a genetically modified lentivirus. Modified lentivirus (HIV-1) vectors retain their ability to infect undivided cells, thereby increasing their ability to transduce a wide variety of cells, including those that are difficult to transduce. This advantage enables the stable long-term expression of a transgene. In immunotherapy, CAR-T cells are manufactured by transducing the CAR gene with an HIV-1 vector in T cells to express a specific chimeric p24 protein on their surface. This allows them to recognize cancer cells and destroy them. These CAR-T cells must be generated individually to treat each patient. This application note demonstrates a comparative quantification of the p24 titer in a lentiviral GFP control sample using Alliance HIV-1 p24 Antigen ELISA and p24 AlphaLISA immunoassay platforms. Check out the different sections of this application note: A lentiviral vector that encodes the CAR construct Determination of the efficiency of transient co-transfection by measuring viral titer Detection of the presence of a p24 HIV-1 specific antibody in the sample Quantification of targets present in the sample

Application Note
Application Note
A fast and simple chemiluminescent assay for monitoring of DNA-protein interactions

Electrophoretic Mobility Shift Assay (EMSA) is a standard technique used to study protein-DNA interactions. It is a radioactive assay, suitable only for low-throughput applications due to the need for a gel-based separation step. AlphaLISA ™ is a bead-based chemiluminescent technology, as a faster, simpler, and non-radioactive alternative to EMSA. AlphaLISA ™ is highly sensitive, requiring less nuclear extract compared to EMSA, highly reproducible, and suitable for higher throughput applications. Revvity developed an AlphaLISA immunoassay to monitor the presence of specific DNA-binding proteins in nuclear extracts. In this application note, we use HepG2 nuclear extracts to demonstrate the binding of Sp1 and HNF1 transcription factors to tagged oligonucleotides containing required cognate response elements. Read this note to see the results and access detailed data compared to EMSA.

Technical Note
Technical Note
A simple method for preparing GPCR membrane model extracts from stable cell lines for use with the HTRF GTP Gi binding assay

G-protein coupled receptors (GPCRs) are crucial transmembrane proteins involved in cellular signal transduction. This technical note outlines a method for preparing GPCR membrane model extracts from stable cell lines, specifically for use with the HTRF GTP Gi binding assay. Get this technical note and discover: Key Highlights such as the Importance of GPCRs and the advantages of using HTRF GTP Gi Binding Assay Detailed Method with Cell Culture Preparation, Cell Lysis, Membrane Preparation and Assay Optimization For research use only. Not for use in diagnostic procedures.

Application Note
Application Note
AAV capsid detection and characterization with new AlphaLISA assay kits

Reliable, Quantitative, and No-Wash Assay Platform for AAV Capsid Detection AAVs are widely used as viral vectors in human gene therapy implementing recombinant DNA technology. Measurement of AAV concentration in complex biological matrices is essential for and effective manufacturing of AAV gene therapies. Revvity has developed and manufactured a line of immunoassays that detect and quantify AAV capsid with AlphaLISA™ technology. These assays can detect AAV1, AAV2, AAV3B, AAV5, AAV6, AAV8, and AAV9 serotypes, and measure AAV particles present in cell culture media, lysis buffer, and cell lysate. Get your application note to: Learn more about AAV capsid detection kits Access data on detection limit, assay reproducibility, variability, specificity, and recovery from multiple analyte matrices through explained diagrams See details on experimental conditions

Whitepaper
Whitepaper
Addressing the challenges of bispecific antibody characterization with high-throughput platforms

Bispecific antibodies (bsAbs) have emerged as an attractive class of therapeutic agents with the potential to revolutionize the treatment of various disorders. While the concept of bsAbs has been around for several decades, it has taken time for the technology and understanding of antibody engineering to advance to a point where its practical application has become feasible. The development of bsAbs demands intricate screening processes to identify candidates with desired binding properties, ensuring they induce specific biological activities. Additionally, achieving optimal tissue tropism and potency requires careful consideration of factors such as antibody size, affinity, and the implementation of innovative characterization strategies. In this context, this whitepaper explores novel approaches contributing to bsAb characterization, offering real-world examples that highlight their practical applications.

Whitepaper
Whitepaper
Adeno-Associated Virus (AAV) Vectors Manufacturing

What Are the Challenges and Solutions? All across the globe, AAVs are getting the attention of scientists and companies working in gene therapy, as they provide the right combination of characteristics that make them one of the most promising vector today. In 2021 only, the global gene therapy market was 4.1 billion USD, and AAV vector therapies made up more than 43% of that market value! Designing and manufacturing AAV vectors is complex, and to be successful, certain challenges must be addressed. This implies monitoring and optimtizing production for a thorough quality control process, including reliable ongoing characterization of process intermediates and the final product. Key features include: Overview and data on the gene therapy market Description of AAV vectors’ genomes and transfer Challenges associated with AAV vectors’ design and manufacturing Analytical methods for AAV vector quality control with a description of innovative no-wash AlphaLISA™ assays

Flyer
Flyer
Advance your biologics research with Revvity solutions

In the dynamic landscape of pharmaceuticals, biotherapeutics research stands out as the fastest-growing sector. Scientists worldwide are on a quest for ever more efficient tools to develop therapeutic proteins. From lead selection to bioprocessing qualification, rigorous analytical characterization is essential. That’s where Revvity steps in. Our comprehensive line of no-wash tools revolutionizes biologics screening, mechanism-of-action studies, and biomanufacturing. With robustness and convenience at the forefront, we empower researchers to accelerate discoveries and drive innovation. Welcome to a new era of precision and efficiency in biotherapeutics research. For research use only. Not for use in diagnostic procedures.

Application Note
Application Note
Advantages of using our automatable and no-wash HTRF and AlphaLISA kits for CHO HCP detection

Detecting and quantifying HCPs with automatable homogeneous immunoassays During biotherapeutic manufacturing and production, the host cells - a great majority of them being Chinese Hamster Ovary (CHO) cells – produce protein impurities that are called Host Cell Proteins (HCPs). Even if more than 99% of them are removed from the final product, the residual CHO HCPs can induce immunogenicity in individuals or reduce the potency, stability, or effectiveness of a drug. Therefore, to meet regulatory organizations’ guidelines (such as FDA or EMA) on CHO HCP levels, biopharmaceutical companies spend significant amounts of money on tools and strategies for their detection. Illustrated with robust results, this Application Note explains the many ways in which HTRF™ and AlphaLISA™ kits can improve the workflow for CHO HCP detection: Wide antibody coverage Compatibility with most commonly used buffers No cross-reactivity between CHO HCP detection and drug substance Good dilutional linearity and antigen spike recovery

Brochure
Brochure
Alpha assays and reagents catalog

Alpha technolgy enables the rapid and straightforward mesaure of virtually any target. This includes enzymes, receptor-ligand interactions, low-affinity interactions, second messenger levels, DNA, RNA, proteins, protein-protein interactions, peptides, sugars and small molecules. Explore the vast selection of homogenous Alpha assays and reagents, including AlphaLISA ™ , AlphaLISA ™ SureFire ® Ultra ™ , AlphaScreen ™ , and Alpha Toolbox. For research use only. Not for use in diagnostic procedures.

Guide
Guide
Alpha Protein-Protein Interaction Quick Start Guide

Alpha has been used to study a wide variety of interactions, including protein:protein, protein:peptide, protein:DNA, protein:RNA, protein:carbohydrate, protein:small molecule, receptor:ligand, and nuclear receptor:ligand interactions. Both cell-based and biochemical interactions have been monitored, and applications such as phage display, ELISA, and EMSA (electrophoretic mobility shift assay) have been adapted to Alpha.

Brochure
Brochure
Alpha SureFire Ultra no-wash immunoassay catalog

Discover Alpha SureFire ®   Ultra ™ assays, the no-wash cellular kinase assays leveraging Revvity's exclusive bead-based technology and sandwich immunoassays for detecting phosphorylated proteins in cells. Offering a quantitative alternative to Western Blotting, Alpha SureFire assays are automation-friendly, easily miniaturized, and proficient in detecting both endogenous and recombinant proteins. Explore our comprehensive portfolio of SureFire Assays, designed to help you elevate and expedite your drug discovery journey.

Whitepaper
Whitepaper
Alpha technologies for antibody detection and characterization

Many laboratories developing and producing antibodies still rely on traditional enzyme-linked immunosorbent assay (ELISA) to perform clonal selection and characterization. Whilst well established, ELISAs can lack sensitivity and reproducibility, and are difficult to automate. In this white paper, you will learn how Alpha Technologies can provide a faster and simpler workflow for antibody detection and characterization. It will take you through key steps such as antibody clonal selection, measuring antibody affinity and characterizing antibodies, providing examples and demonstrating the advantages Alpha technology can provide as an alternative to ELISA. Download the white paper to discover how to advance your antibody detection and characterization.

Application Note
Application Note
Alpha technology: a fast and sensitive orthogonal approach to cell-based potency assays

Orthogonal systems to cell-based assays are a key requirement in EMA/FDA guidelines for potency estimations and require cross-validation with complementary approaches to prove and strengthen the reliability of results. In this application note published in collaboration with IBR Inc., you will learn: Why Alpha technology represents an ideal cell-free orthogonal system for potency assays How AlphaLISA assays can be used to determine Bevacizumab/VEGF165 potency An example of how to run an AlphaLISA potency assay and the type of data that can be generated Why it is suitable for assessing lot-to-lot consistency and equivalence of Bevacizumab and biosimilars

Technical Note
Technical Note
AlphaLISA Acetyl‑Histone H3 lysine 27 (H3K27ac) cellular detection kit

Quantifying H3K27ac Levels with AlphaLISA Assay In this technical note, you will discover how AlphaLISA immunodetection assay easily detects alterations in acetylated histone H3 lysine 27 (H3K27ac) levels within cellular extracts.

Technical Note
Technical Note
AlphaLISA Acetyl‑Histone H3 lysine 9 (H3K9ac) cellular assay

Quantifying H3K9ac in Cellular Extracts with AlphaLISA This technical note gives you details about how AlphaLISA immunodetection assay monitors changes in the levels of acetylated histone H3 lysine 9 (H3K9ac) in cellular extracts.

Guide
Guide
AlphaLISA assay development guide

The AlphaLISA technology allows the detection of molecules of interest in serum, plasma, cell culture supernatants or cell lysates in a very sensitive, quantitative, reproducible, and user-friendly assay. Almost, any sandwich assay can be developed to detect an analyte of interest. Discover how to simply your immunoassay workflow with this guide! For research use only. Not for use in diagnostic procedures.

Technical Note
Technical Note
AlphaLISA assays for immune checkpoint detection and quantitation

Quantifying Immune Checkpoints: AlphaLISA Biomarker Detection Kits This technical note focuses on the role of checkpoint molecules in cancer immunotherapies. Checkpoint molecules are molecular markers that can regulate an immune system attack on cancer cells. They have gained prominence as promising candidates for immunotherapies. AlphaLISA detection kits are designed to detect and quantify the levels of these molecules in cell culture media, serum, and cell lysates.

Technical Note
Technical Note
AlphaLISA Di-Methyl-Histone H3 lysine 4 (H3K4me2) cellular assay

Decoding Histone Modifications: A Targeted Assay for H3K4me2 In this study, you will find details about an optimized assay designed to quantify changes in H3K4me2 levels following treatment with sodium butyrate and Trichostatin A (TSA), both of which are non-selective histone deacetylase (HDAC) inhibitors. Using a standardized histone extraction procedure, we detect the target mark by employing a biotinylated anti-Histone H3 (C-terminus) antibody and AlphaLISA Acceptor beads conjugated to an antibody specific to the mark.

Technical Note
Technical Note
AlphaLISA Di/Mono-Methyl-Histone H3 Lysine 27 (H3K27me2-1) cellular detection kit

Quantification of H3K27me3 Levels Using AlphaLISA Technology In this technical note discover how AlphaLISA ™ immunodetection assay tracks variations in cellular extract levels of di-methylated histone H3 lysine 27 (H3K27me2-1).

Technical Note
Technical Note
AlphaLISA DOT1L histone H3 lysine-N-methyltransferase assay

Unlocking the secrets of epigenetics, our technical not dives into optimizing a DOT1L enzymatic assay This technical document outlines the optimization of a DOT1L enzymatic assay using oligonucleosomes as the substrate. Discover how the assay easily detects the dimethylated product of histone H3 lysine 79 by leveraging a biotinylated anti-H3K79me2 antibody, which binds to the epigenetic mark of interest.

Technical Note
Technical Note
AlphaLISA EZH2 Histone H3-Lysine 27 N-methyltransferase assay

Lysine 27 Dimethylation Detection with AlphaLISA Technology In this technical note discover how AlphaLISA immunodetection assay detects dimethylation of a biotinylated Histone H3 (21-44) peptide at lysine 27. It uses anti-di/mono-methyl-Histone H3 Lysine 27 (H3K27me2-1) as the detection antibody.

Technical Note
Technical Note
AlphaLISA for biomarkers in urine: Measuring the renal tubular injury indicator, β2-microglobulin

AlphaLISA ™ Detects β2-Microglobulin in Urine with High Sensitivity When kidney tubular function is impaired, elevated levels of β2-microglobulin in urine indicate renal filtration or reabsorption disorders. Measuring urinary β2-microglobulin can help assess tubular function, but variability in urine composition may affect results. In this study, AlphaLISA ™ technology is demonstrated for the first time in the complex matrix of urine, and is shown to detect the renal tubular injury marker Beta2-microglobulin (β2-microglobulin), in urine at a sensitivity of 77 pg/mL.

Technical Note
Technical Note
AlphaLISA G9a Histone H3-Lysine N-methyltransferase assay

Quantification of Histone H3 Lysine 9 Di-Methylation Using AlphaLISA Assay In this technical note discover how The AlphaLISA assay detects di-methylation of a biotinylated Histone H3 (1-21) peptide at lysine 9. In this assay, a biotinylated histone H3-derived peptide serves as the substrate, and the modified substrate is detected using Streptavidin (SA) Alpha Donor beads and AlphaLISA Acceptor beads conjugated to an antibody specific to the epigenetic mark of interest.

Technical Note
Technical Note
AlphaLISA HDAC1 Histone H3-Lysine 27 deacetylase assay

AlphaLISA Assay Insights: Tracking Deacetylation Dynamics on Histone H3 Peptides In this technical note discover how this AlphaLISA assay is designed to detect the removal of acetyl groups from a biotin-tagged peptide derived from Histone H3, specifically the segment from amino acids 21 to 44, which has been acetylated at the lysine 27 position. For research use only. Not for use in diagnostic procedures.

Guide
Guide
AlphaLISA immunoassay conversion quick start guide

This quick guide presents a fast proof-of concept experiment to easily convert a immunoassay to a no-wasy AlphaLISA assay.